Perceptive Advisors LLC 13D and 13G filings for RAPT Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:15 pm Purchase | 2024-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | Perceptive Advisors LLC | 735,000 4.500% | 467,506 (+174.77%) | Filing |
| 2024-02-14 4:41 pm Purchase | 2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | Perceptive Advisors LLC | 267,494 6.200% | 42,624 (+18.96%) | Filing |
| 2023-02-14 2:31 pm Sale | 2022-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | Perceptive Advisors LLC | 224,869 5.300% | -141,076 (-38.55%) | Filing |
| 2022-02-14 5:30 pm Purchase | 2021-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | Perceptive Advisors LLC | 365,946 9.900% | 168,761 (+85.58%) | Filing |
| 2021-02-16 3:31 pm Purchase | 2020-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | Perceptive Advisors LLC | 197,185 6.400% | 31,250 (+18.83%) | Filing |
| 2020-12-14 08:33 am Purchase | 2020-12-04 | 13G | RAPT Therapeutics, Inc. RAPT | Perceptive Advisors LLC | 165,935 5.400% | 165,935 (New Position) | Filing |